Welcome to the Mirati Investigator Research Portal!
The
Mirati Investigator Research Portal will enable you to submit your investigator-sponsored research (ISR) proposal for review, track the progress of your existing proposal, and report on ongoing studies.
Mirati determines research support based upon:
- scientific merit of the proposal
- alignment with the company’s development plans and strategic research interest
- patient safety in terms of dosing or interactions
- and study feasibility to accomplish the research objectives
Mirati supports research which may include clinical, translational, or non-clinical research and be of interventional or non-interventional design.
A complete study proposal must be submitted by the research investigator or their affiliate and should contain:
- a well thought out study rationale
- clear primary objective with supportive endpoints
- cohesive study design
- statistical analysis plan and sample size calculation
- study and publication timelines
- for research requesting financial support, an estimated total budget must be provided with the proposal.
All required submission fields must be complete and requested documents uploaded for Mirati to consider review of your application. Submission of an application does not guarantee approval. All proposals are reviewed by a cross-functional Review Committee, which includes Mirati medical directors, scientists, biostatisticians, and experts in drug safety, health outcomes and pharmacoeconomics.
Should you have any questions regarding the Mirati ISR program and/or its submission process, please contact your local field medical representative or the Mirati Medical Affairs ISR administrator at:
medaffairsresearch@mirati.comFor technical assistance with the ISR portal, please contact client services by phone: +1-718-576-1406, M–F 9am-8pm ET or Email:
support@steeprockinc.com Thank you in your interest in working with Mirati Therapeutics where we are
Relentlessly Focused on What Matters to Patients.
